Insight Diagnostic And Oncological Research Institute Profile
Key Indicators
- Authorised Capital ₹ 4.00 M
as on 28-12-2024
- Paid Up Capital ₹ 3.33 M
as on 28-12-2024
- Company Age 35 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.00 M
as on 28-12-2024
- Satisfied Charges ₹ 1.12 Cr
as on 28-12-2024
About Insight Diagnostic And Oncological Research Institute
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.00 M and a paid-up capital of Rs 3.33 M.
The company currently has active open charges totaling ₹2.00 M. The company has closed loans amounting to ₹1.12 Cr, as per Ministry of Corporate Affairs (MCA) records.
Nandkumar Joshi, Ghanasham Heda, Sanjay Karnawat, and One other member serve as directors at the Company.
- CIN/LLPIN
U85110MH1989PTC050530
- Company No.
050530
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Jan 1989
- Date of AGM
10 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- LocationNa, Maharashtra
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Insight Diagnostic And Oncological Research Institute?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nandkumar Joshi  | Director | 31-Jan-1989 | Current |
| Ghanasham Heda | Director | 31-Jan-1989 | Current |
| Sanjay Karnawat | Director | 30-Nov-2021 | Current |
| Shekhar Karnawat | Director | 31-Jan-1989 | Current |
Financial Performance of Insight Diagnostic And Oncological Research Institute.
Insight Diagnostic And Oncological Research Institute Pvt Ltd, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Insight Diagnostic And Oncological Research Institute?
In 2017, Insight Diagnostic And Oncological Research Institute had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Nidan Healthcare LimitedActive 27 years 8 monthsNandkumar Joshi, Ghanasham Heda and 2 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of Baroda Creation Date: 25 Jun 2007 | ₹2.00 M | Open |
Bank Of Baroda Creation Date: 06 Apr 2005 | ₹1.40 M | Satisfied |
The Ratnakar Bank Ltd. Creation Date: 30 Mar 2001 | ₹4.80 M | Satisfied |
How Many Employees Work at Insight Diagnostic And Oncological Research Institute?
Unlock and access historical data on people associated with Insight Diagnostic And Oncological Research Institute, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Insight Diagnostic And Oncological Research Institute, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Insight Diagnostic And Oncological Research Institute's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
